ERG and prostate carcinoma: Clonal proliferation of NED from an existing prostate cancer is indicated by the prostate cancer specific gene rearrangement TMPRSS2-ERG in NED prostate cancer cases, that most commonly appears following hormonal therapy of hormone sensitive prostate cancer [86].